Abstract:Some inborn errors of metabolism due to deficiencies of soluble lysosomal enzymes cause global neurodegenerative disease. Representative examples include the infantile and late infantile forms of the ceroid lipofuscinoses (CLN1 or CLN2 deficiency, respectively) and mucopolysaccharidoses type VII (MPS VII), a deficiency of beta-glucuronidase. Treatment of the central nervous system component of these disorders will require widespread protein or enzyme replacement, either through dissemination of the protein or through dissemination of a gene encoding it. We hypothesize that transduction of brain microcapillary endothelium (BME) with recombinant viral vectors, with secretion of enzyme product basolaterally, could allow for widespread enzyme dissemination. To achieve this, viruses should be modified to target the BME. This requires (i) identification of a BME-resident target receptor, (ii) identification of motifs targeted to that molecule, (iii) the construction of modified viruses to allow for binding to the target receptor, and (iv) demonstrated transduction of receptor-expressing cells. In proof of principal experiments, we chose the human transferrin receptor (hTfR), a molecule found at high density on human BME. A nonamer phage display library was panned for motifs which could bind hTfR. Forty-three clones were sequenced, most of which contained an AKxxK/R, KxKxPK/R, or KxK motif. Ten peptides representative of the three motifs were cloned into the HI loop of adenovirus type 5 fiber. All motifs tested retained their ability to trimerize and bind transferrin receptor, and seven allowed for recombinant adenovirus production. Importantly, the fiber-modified viruses facilitated increased gene transfer (2- to 34-fold) to hTfR expressing cell lines and human brain microcapillary endothelia expressing high levels of endogenous receptor. Our data indicate that adenoviruses can be modified in the HI loop for expanded tropism to the hTfR.

Improvement of Cellular Adenovirus Uptake with TAT Peptide is Cell-type Dependent

Genetically Modified Adenoviral Vector with the Protein Transduction Domain of Tat Improves Gene Transfer to CAR-deficient Cells

Design and synthesis of a Tat-related gene transporter: a tool for carrying the adenovirus vector into cells.

Enhancement of adeno-associated virus serotype 6 transduction into T cells with cell-penetrating peptides

Intracellular Transduction and Potential of Tat PTD and Its Analogs: from Basic Drug Delivery Mechanism to Application

A targeting peptide improves adenovirus-mediated transduction of a glioblastoma cell line.

Enhanced Nuclear Import and Transfection Efficiency of Tat Peptide-Based Gene Delivery Systems Modified by Additional Nuclear Localization Signals

TAT Protein Transduction Domain Mediates Transmembrane Delivery of EGFP into Tissue Cells of Mice in Vivo

Characterisation of cell-penetrating peptide-mediated peptide delivery

Intracellular traffic and fate of protein transduction domains HIV-1 TAT peptide and octaarginine. Implications for their utilization as drug delivery vectors

Protein transduction technology: a novel therapeutic perspective

Tat-conjugated hyaluronic acid enveloping polyplexes with facilitated nuclear entry and improved transfection

Advances in Translocation Domain

Combination of Adenovirus and Cross-Linked Low Molecular Weight PEI Improves Efficiency of Gene Transduction.

Recombinant Human Adenovirus: Targeting to the Human Transferrin Receptor Improves Gene Transfer to Brain Microcapillary Endothelium

Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis

Adenovirus serotype 5 vectors with Tat-PTD modified hexon and serotype 35 fiber show greatly enhanced transduction capacity of primary cell cultures

Molecular Mechanism of HIV-1 TAT Peptide and Its Conjugated Gold Nanoparticles Translocating Across Lipid Membranes

Preparation and bioactivity of anti-Newcastle disease virus-phosphoprotein cytoplasmic transduction peptide antibody

The Characterization of Modified Adenovirus Vector

Oligohistidine and targeting peptide functionalized TAT-NLS for enhancing cellular uptake and promoting angiogenesis in vivo